Cover Image

Innovation Process and Industrial System of US Food and Drug Administration-Approved Software as a Medical Device: Review and Content Analysis

BackgroundThere has been a surge in academic and business interest in software as a medical device (SaMD). SaMD enables medical professionals to streamline existing medical practices and make innovative medical processes such as digital therapeutics a reality. Furthermore, SaMD is a billion-dollar m...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jiakan Yu (Author), Jiajie Zhang (Author), Shintaro Sengoku (Author)
Format:	Book
Published:	JMIR Publications, 2023-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Low rates of patient-reported outcome claims for orphan drugs approved by the us food and drug administration
by: Szymon Jarosławski, et al.
Published: (2018)

In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
by: Jingjing Yu, et al.
Published: (2020)

Trends in amorphous solid dispersion drug products approved by the U.S. Food and Drug Administration between 2012 and 2023
by: Dana E. Moseson, et al.
Published: (2024)

Dose Finding in the Clinical Development of 60 US Food and Drug Administration-Approved Drugs Compared With Learning vs. Confirming Recommendations
by: Yassine Kamal Lyauk, et al.
Published: (2019)

Exploring the Food and Drug Administration's review and approval of Entresto (sacubitril/valsartan)
by: Ashley L. Eadie, et al.
Published: (2021)

US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
by: Stacy S. Shord, et al.
Published: (2023)

Defibrotide (Defitelio): A New Addition to the Stockpile of Food and Drug Administration-approved Oligonucleotide Drugs
by: Cy Stein, et al.
Published: (2016)

Use of Titration as a Therapeutic Individualization Strategy: An Analysis of Food and Drug Administration-Approved Drugs
by: Robert N. Schuck, et al.
Published: (2019)

Efficacy End Points and Dose Analysis of Food and Drug Administration-Approved Novel Drugs in 2020
by: Albert Tang
Published: (2022)

Fingolimod: The first oral drug approved by food and drug administration; A breakthrough in treatment of multiple sclerosis
by: Manish Singh, et al.
Published: (2011)

Increased Confidence in Deduplication of Drug Safety Reports with Natural Language Processing of Narratives at the US Food and Drug Administration
by: Kory Kreimeyer, et al.
Published: (2022)

Adaptation of software with the nursing process for innovation units
by: Camila Santana Domingos, et al.
Published: (2019)

Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU
by: Ebru Demirci, et al.
Published: (2023)

A systematic review of Ebola virus disease outbreaks and an analysis of the efficacy and safety of newer drugs approved for the treatment of Ebola virus disease by the US Food and Drug Administration from 2016 to 2020
by: Palanisamy Sivanandy, et al.
Published: (2022)

A U.S. Food and Drug Administration perspective on cannabis research and drug development
by: Cassandra L. Taylor, et al.
Published: (2023)

An overview of FDA-approved vaccines & their innovators
by: Rebekah H. Griesenauer, et al.
Published: (2017)

Food Industrial Processes Methods and Equipment
Published: (2012)

Innovative Food Products and Processing
Published: (2023)

Innovations in the infant food industry - into the practice of pediatricians
by: article Editorial
Published: (2023)

Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration.
by: Robert K M Choy, et al.
Published: (2020)

Assessing adverse drug reaction reports for antidiabetic medications approved by the food and drug administration between 2012 and 2017: a pharmacovigilance study
by: Britney A. Stottlemyer, et al.
Published: (2023)

Competition and Innovation in the U.S. Fixed-Wing Military Aircraft Industry
by: Birkler, John
Published: (2003)

Drug approval processes: A case study of rivaroxaban
by: Sally A Arif, et al.
Published: (2013)

Quantitative systems pharmacology: Landscape analysis of regulatory submissions to the US Food and Drug Administration
by: Jane P. F. Bai, et al.
Published: (2021)

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control
by: Yogendra Keche
Published: (2010)

Review of regulatory requirements in the US, EU and Serbia on software: Mobile application as a medical device: State of the art
by: Vukmirović Dušan, et al.
Published: (2022)

Is innovative workforce planning software the solution to NHS staffing and cost crisis? An exploration of the locum industry
by: Iakovos Theodoulou, et al.
Published: (2018)

Pediatric dosing for locally acting drugs in submissions to the U.S. Food and Drug Administration between 2002 and 2020
by: Gelareh A. Abulwerdi, et al.
Published: (2023)

Drug-induced tooth discoloration: An analysis of the US food and drug administration adverse event reporting system
by: Jun Wang, et al.
Published: (2023)

Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system
by: Ying Zhang, et al.
Published: (2023)

Evaluation of a natural language processing tool for extracting gender, weight, ethnicity, and race in the US food and drug administration adverse event reporting system
by: Vivian Dang, et al.
Published: (2022)

Saving the tourism industry with staycation vouchers [version 1; peer review: 2 approved, 1 approved with reservations]
by: Marko Ogorevc, et al.
Published: (2020)

Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies
by: Rajiv Mahajan, et al.
Published: (2010)

Social Network Analysis in the Legislative Process in the Korean Medical Device Industry
by: Munjae Lee PhD, et al.
Published: (2018)

How independent is the international food information council from the food and beverage industry? A content analysis of internal industry documents
by: Daniel A. Zaltz, et al.
Published: (2022)

Reproducible Analysis Pipeline for Data Streams: Open-Source Software to Process Data Collected With Mobile Devices
by: Julio Vega, et al.
Published: (2021)

The FDA-Approved Essure Device Counseling Order Fails to Promote Patient Empowerment
by: Christine M. Gunn, et al.
Published: (2019)

Analysis of the Association of Administration of various glucocorticoids with development of acute pancreatitis using US Food and Drug Administration adverse event reporting system (FAERS)
by: Daisuke Nango, et al.
Published: (2019)

Portable Bio/Chemosensoristic Devices: Innovative Systems for Environmental Health and Food Safety Diagnostics
by: Roberto Dragone, et al.
Published: (2017)

The effective and innovative cost saving of software in managing unregistered drugs
by: Nur Wahida Zulkifli, et al.
Published: (2015)